DT-001

N/A

Report date: 2023/06/14 16:38:03

Base Information

Drug NameDT-001
Drug Alias NameDT-001
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionAnti-Tumor necrosis factor receptor superfamily member 1B
TargetsTumor necrosis factor receptor superfamily member 1B
Therapy Area/IndicationsImmune System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgium
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesDualyx NV
China Registration ClassN/A

Develop Information

Active CompaniesDualyx NV
Inactive CompaniesN/A
Active IndicationsImmune System Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A